Literature DB >> 16249503

LBP and CD14 secreted in tears by the lacrimal glands modulate the LPS response of corneal epithelial cells.

David R Blais1, Sandy G Vascotto, May Griffith, Illimar Altosaar.   

Abstract

PURPOSE: Lipopolysaccharide (LPS) is one of the most powerful bacterial virulence factors in terms of proinflammatory properties and is likely to contribute to corneal bacterial keratitis. Better understanding of the spatial expression of the LPS receptor components at the tear-corneal interface might facilitate enhanced functions of the LPS receptor complex in ocular defense against Gram-negative infections.
METHODS: The expression of LPS-binding protein (LBP), CD14, toll-like receptor (TLR)-4, and MD-2 in human lacrimal glands, reflex tears, and corneal epithelia was examined by ELISA, RT-PCR, Western blot analysis, and immunofluorescence. The release of proinflammatory cytokines after the activation of primary and immortalized corneal epithelial cells with LPS and human tears was measured by ELISA.
RESULTS: LBP and CD14 proteins were detected in reflex human tears. Human lacrimal glands and corneal epithelia expressed LBP, CD14, TLR4, and MD-2 mRNAs and proteins. In the corneal epithelium, LBP was mainly expressed by superficial and basal epithelial cells, whereas CD14, TLR4, and MD-2 expression were limited to the wing and basal epithelial cells. In a dose-dependant manner, tear CD14 and LBP mediated the secretion of interleukin (IL)-6 and IL-8 by corneal epithelia cells when challenged with LPS.
CONCLUSIONS: Tear CD14 and LBP complemented the LPS receptor complex expressed by the corneal epithelia to trigger an immune response in the presence of LPS. The complementation of these tear and corneal immune proteins could play an important role in LPS recognition and signaling and, therefore, could modulate ocular innate immunity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16249503     DOI: 10.1167/iovs.05-0543

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  28 in total

1.  Low-level diode laser therapy reduces lipopolysaccharide (LPS)-induced bone cell inflammation.

Authors:  Tsui Hsien Huang; Yu Chuan Lu; Chia Tze Kao
Journal:  Lasers Med Sci       Date:  2011-10-16       Impact factor: 3.161

Review 2.  Toll-like receptors in ocular surface disease.

Authors:  Rachel L Redfern; Alison M McDermott
Journal:  Exp Eye Res       Date:  2010-03-24       Impact factor: 3.467

3.  Levels of soluble CD14 and lipopolysaccharide-binding protein in human basal tears.

Authors:  Ken Fukuda; Naoki Kumagai; Teruo Nishida
Journal:  Jpn J Ophthalmol       Date:  2010-06-25       Impact factor: 2.447

Review 4.  Toll-like receptors and the eye.

Authors:  Fu-Shin X Yu; Linda D Hazlett
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-04       Impact factor: 4.799

Review 5.  Toll-like receptors and corneal innate immunity.

Authors:  Ashok Kumar; Fu-Shin X Yu
Journal:  Curr Mol Med       Date:  2006-05       Impact factor: 2.222

6.  The role of toll-like receptor 4 in corneal epithelial wound healing.

Authors:  Medi Eslani; Asadolah Movahedan; Neda Afsharkhamseh; Herve Sroussi; Ali R Djalilian
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-09-02       Impact factor: 4.799

7.  Bone marrow chimeras and c-fms conditional ablation (Mafia) mice reveal an essential role for resident myeloid cells in lipopolysaccharide/TLR4-induced corneal inflammation.

Authors:  Holly R Chinnery; Eric C Carlson; Yan Sun; Michelle Lin; Sandra H Burnett; Victor L Perez; Paul G McMenamin; Eric Pearlman
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

Review 8.  Toll-like receptors at the ocular surface.

Authors:  Eric Pearlman; Angela Johnson; Gautam Adhikary; Yan Sun; Holly R Chinnery; Todd Fox; Mark Kester; Paul G McMenamin
Journal:  Ocul Surf       Date:  2008-07       Impact factor: 5.033

9.  Modulation of corneal epithelial innate immune response to pseudomonas infection by flagellin pretreatment.

Authors:  Ashok Kumar; Jia Yin; Jing Zhang; Fu-Shin X Yu
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

10.  Hypoxia-altered signaling pathways of toll-like receptor 4 (TLR4) in human corneal epithelial cells.

Authors:  Yuko Hara; Atsushi Shiraishi; Yuichi Ohashi
Journal:  Mol Vis       Date:  2009-12-02       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.